Abstract Abnormal fat deposition in the epidural space or spinal epidural lipomatosis (SEL) due to corticosteroid treatment or obesity may cause obstruction to cerebrospinal fluid flow. Little is known about SEL in patients with hematologic malignancies who require frequent lumbar punctures and corticosteroid treatment that places them at risk. Records and radiologic images of patients with SEL and leukemia or non-Hodgkin lymphoma (NHL) treated at a single institution from 1999-2009 were reviewed. Risk factors were compared with 405 control patients with leukemia. Fourteen patients with leukemia or NHL were diagnosed with SEL.
sac and vascular compromise [5, 6] . Crowding of the dural sac may also impede collection of CSF by LP. SEL has been associated with long-term use of exogenous corticosteroids for solid-organ transplants and other conditions [7] , endogenous steroid excess or hypercortisolism [8] , druginduced lipodystrophy [9] , and obesity [10] . Idiopathic (primary) SEL has been described in patients without known risk factors [5, 11] . Patients with hematologic malignancies often receive long-term high-dose corticosteroid therapy, but with the exception of isolated case reports [12, 13] , this group is conspicuously missing from the SEL literature. Importantly, central nervous system (CNS)-directed therapy may be compromised by an inability to perform routine LPs successfully due to SEL. We review the clinical implications of this diagnosis in 14 patients with hematologic malignancies treated at a single institution.
Methods

Study population
Patients for review were identified through a search of the diagnostic imaging electronic records database (Cerner Classic PathNet and Cerner Millennium). "Lipomatosis" was queried in spinal magnetic resonance imaging (MRI) electronic records for patients with leukemia and non-Hodgkin lymphoma (NHL) treated between January 1, 1999 and December 31, 2009. Overall, 14 patients were identified with a total of 22 diagnostic reports. For comparison of risk factors that may be associated with SEL, a cohort of 405 consecutive patients with newly diagnosed acute lymphoblastic leukemia (ALL) was analyzed. These patients were treated at on the Total study XV during a similar time period (June 2000 to October 2007) [14] .
This study was approved by the St. Jude Children's Hospital institutional review board.
Assessment and definition of potential risk factors
A retrospective review of medical records identified pertinent clinical and laboratory features, management, and outcome. Treatment-specific information included cumulative corticosteroid dose and total number of LPs with intrathecal medications prior to SEL diagnosis. All corticosteroid doses were converted to oral prednisone equivalent doses (milligrams per square meter) for uniform analysis. All patients had at least two (range, 2-22; median, 4) successful LPs prior to SEL diagnosis.
Patients 2-19 years of age were classified as overweight (body mass index (BMI) between 85-95th percentile) or obese (BMI >95th percentile) at the time of malignancy diagnosis (http://www.cdc.gov/obesity). For older patients, BMI >30 is considered obese and 25-29.9 overweight. Dyslipidemia was established using the National Cholesterol Education Program guidelines: total cholesterol, >200 mg/dL; low-density lipoprotein, >130 mg/dL; high-density lipoprotein (HDL), <35 mg/dL; and triglyceride, >130 mg/dL (10-19 years old) or >100 mg/dL (0-9 years old) [15] .
The definition of CNS involvement has been described previously [1] . An LP was classified as traumatic if the CSF contained at least 10 RBCs per microliter [16] . Finally, a "difficult LP" was defined as a procedure, under otherwise optimal conditions, that required multiple attempts (≥3) or where flow was slower than one drop of CSF every 3-5 s.
Radiology
MRIs were reviewed by a single neuroradiologist (KH). Sagittal T1-(repetition time (TR), 400-698; echo time (TE), 9-13 ms) and T2-weighted (TR, 4,000-6,570;TE, 82-116 ms) images of the spine with 5 mm contiguous axial T1-(TR, 400-1,140; TE, 10-12 ms) and T2W-weighted (TR, 4,380-9,280; TE 89-90 ms) images perpendicular to the vertebral bodies were acquired through areas of thecal sac narrowing. Fat saturation techniques were utilized in seven cases. Measurements (in millimeters) of the width of the spinal canal at the point of maximal SEL (L4-5) were compared to the canal's widest measurement (L2-3). MRI at diagnosis of SEL and, when available, the most recent spinal MRI were reviewed for comparison. Images were also evaluated for congenital spinal canal narrowing, vertebral bony changes, or ligament hypertrophy that could contribute to canal narrowing independent of SEL by comparing measurements of the dural sac diameter at L2, L4, and L5 with published normal values [17] . Finally, visibility of CSF at L4-5 level despite the presence of SEL was noted.
Statistical analyses
To study the association of clinical and laboratory risk factors with the development of SEL, 14 patients (SEL cases) were compared to 405 patients with newly diagnosed ALL (controls). The exact chi-square test was used for binary variables and the Wilcoxon signed rank test for continuous variables.
Results
Clinical characteristics
From January 1, 1999 to December 31, 2009, 716 patients with ALL, 238 patients with acute myeloid leukemia (AML), and 174 patients with NHL were treated at St. Jude Children's Research Hospital. Of these 1,128 patients, 14 were diagnosed with SEL (incidence, 1.2%). The five female and nine male patients ranged in age between 3.9 and 22.6 years (median, 13 years) at the time of diagnosis of malignancy (Table 1) . Ten patients were diagnosed with leukemia: five B-cell precursor ALL (including two with late marrow relapse), four T-cell ALL, and one AML. Four patients had NHL: two diffuse large B-cell lymphoma, one T-cell lymphoblastic lymphoma (SEL diagnosed at the time of early isolated CNS relapse), and one Burkitt lymphoma. Five patients (nos. 1, 2, 3, 6, and 14) had CNS2 disease at diagnosis. Initial lumbar puncture was traumatic with blasts in two patients (nos. 1 and 6).
Diagnosis and imaging of spinal epidural lipomatosis SEL was diagnosed in 10 patients within 1 month after starting therapy (range, 8 to 30 days). The two patients with relapsed ALL were diagnosed with SEL at 18 months (no. 8) and 98 days (no. 9) after initiation of relapse therapy. Patient 13 with CNS relapse of NHL was diagnosed with SEL 118 days after initial diagnosis, but only 20 days after disease relapse.
The indication for MRI in the majority of patients (n=10) was "difficult LP." In retrospect, one patient (no. 11) also complained of mild numbness in the extremities prior to SEL diagnosis; however, the neurologic examination was normal. Three patients had low back pain, one of whom (no. 3) presented at diagnosis with compression fractures due to presumed leukemic infiltrates. One patient had MRI performed for signs of neurologic weakness while being treated for suspected sepsis (no. 14), and one patient with gluteal cleft drainage had imaging to rule out a fistula (no. 6).
Risk factors
Five patients were overweight and three were obese at the time of their malignancy diagnosis. At least one abnormality was noted in the lipid profiles of 10 patients in whom complete information was available at diagnosis of malignancy. Eight patients had low HDL levels (range, 19-32), nine patients had high triglyceride levels (range, 120-288), and one patient had a high total cholesterol level (202 mg/dL).
The total systemic prednisone equivalent corticosteroid dose received by patients with ALL or NHL (excluding those with relapse) prior to SEL diagnosis ranged from 355 to 1,167 mg/m All patients received intrathecal administration of hydrocortisone prior to SEL diagnosis. In 11 patients without When compared to patients with newly diagnosed ALL, black race, older age, high BMI percentile for age, and presence of CNS disease at diagnosis were identified as risk factors for developing SEL (Table 2 ). Patients with SEL had higher median HDL levels, but differences in the other parameters of the lipid profile did not reach statistical significance.
Radiology
Spinal epidural lipomatosis involved the posterior thoracic, lumbar, and sacral spinal canal in 13 patients; patient 8 had lumbar and sacral SEL only (Table 3) . In seven patients, SEL was also noted in the anterior portion of the lumbar canal (nos. 2, 3, 5, 6, 11, 12, and 13) . In five patients, canal Percentage of canal narrowing due to SEL was determined by comparing the canal width at L4-5 to the widest part of the canal in the lumbar region at L2 in the same patient. Age-matched normal reference values identified vertebral body diameter and dural sac diameter only and could not be used for comparison [17] . In our patient cohort, this ratio ranged from 0.52 to 1, indicating that the canal was narrowed by 0-48% by fat deposition at L4-5. All patients also had varying degrees of fat deposition at the L2 level, thus, this ratio may not be truly reflective in some patients and underestimates the true extent of narrowing at L4-5. The presence or absence of anterior fat deposition was included as a marker of the severity of lipomatosis only since it does not interfere with the clinical procedure. These data are shown in Table 3 .
Management of SEL
Ten patients were diagnosed with SEL due to difficulty in performing LP (nos. 1, 2, 3, 4, 5, 7, 8, 11, 12, and 13). Ommaya reservoir was placed for continued intrathecal therapy in four patients (nos. 2, 4, 7, and 13). (Fig. 2) . Following review of MRIs, subsequent LPs were successful in patient 8 under fluoroscopy and in patients 3, 5, and 11 by inserting the spinal needle in the adjacent intervertebral space which demonstrated a lesser degree of obstruction. Since CSF was clearly visible at L4-5 for patient 12 despite 
Outcome
None of the patients required surgical procedures, such as decompression, for management of SEL. Follow-up imaging was available for five patients (nos. 2, 4, 6, 12, and 13) at various time points after SEL diagnosis (range, 1 to 22 months). Due to limited follow-up studies, the natural history of SEL could not be studied, though all five patients demonstrated gradual improvement in the extent of SEL (data not shown). All patients continued protocol-specified chemotherapy without alterations in doses of systemic corticosteroids or CNS-directed therapy due to SEL. Twelve patients are in remission from their malignancy for a median of 2.4 years (range, 0.4 to 7.5 years). Patient 14 with AML developed bone marrow relapse and subsequently died. Patient 13 with relapsed NHL also died of progressive disease.
Discussion
Frequent lumbar punctures are essential in the management of childhood hematological malignancies [1] . This procedure may be complicated by red blood cell contamination or poorly flowing CSF. Previously, we have identified risk factors that may be modified to reduce the incidence of traumatic taps [18] . In this retrospective review, we identify another potentially modifiable factor, SEL, that may lead to difficult LPs. Though SEL is an uncommon condition with only 104 cases in a recent literature review [7] , we have identified 14 cases in our leukemia/lymphoma treatment population over the past decade. Since SEL can impede the optimal delivery of intrathecal medications, we identified risk factors of steroid administration, age, race, and obesity as well as guidelines for management in this treatment population.
A limitation of this retrospective review is the lack of use of an established grading system for measuring extent of SEL in pediatrics. An objective MRI grading system for adults with SEL has been previously published [19] . This technique utilizes linear measurements in the axial plane, parallel and tangent to the superior end plate of S1 vertebral body. Conventional MRI does not capture images in this specific plane, and it was not feasible to reconstruct the images in the axial plane while maintaining imaging detail. Thus, in our analysis, we quantified the extent of SEL by comparing the widest measurement at L2 with the width of the canal at maximal compression specifically focusing at the clinically relevant L4-5 level. In our patient cohort, SEL compromised the width of the lumbar canal by a range of 13-48%. When coupled with comorbidities such as congenital spinal canal narrowing, degenerative vertebrae, or ligament hypertrophy, this presents a potentially significant obstacle to subsequent intrathecal treatment. Capturing spinal images utilizing techniques similar to Borre et al. could improve comparison to adult grading systems for future patients, but a pediatric grading system has not yet been established and would likely be more beneficial in correlating SEL with management considerations in this population. While the most common presenting features of SEL in adult patients are neurologic symptoms of back pain and sensory and/or motor difficulties [7] , children may present with more subtle findings. In the study by Kano et al. [20] , an MRI was performed in children receiving chronic steroid therapy for renal disorders if they were obese or if they complained of symptoms of SEL, such as back pain or numbness. SEL was diagnosed in 5 of 125 (4%) patients who all had clinical symptoms and 4 were obese. The true incidence of subclinical SEL may have been higher. In our study, the majority of patients with SEL did not exhibit symptoms and were diagnosed after difficult or failed LP attempts.
In addition to steroid treatment, obesity has been linked to SEL. In our cohort, 8/14 patients were overweight or obese. Abnormal lipid profiles are a significant comorbidity with obesity and were investigated as additional risk factors for development of SEL. Of the 10 patients with available lipid profiles, all patients had at least one abnormal value, but it was not possible to determine if all panels were Fig. 2 Axial T2-weighted MRI, L4-5 level for patient no. 13. Epidural fat completely surrounds and compresses spinal cord nerve roots (small arrows). Note facet hypertrophy (big arrows) which further narrows the canal. This patient also has abundant subcutaneous fat obtained during a fasting state. In addition, lipid panels were not obtained after initiation of corticosteroids, thus, we could not ascertain whether deranged lipids post corticosteroids further promoted abnormal fat deposition in the spinal canal. Finally, we cannot exclude familial influences on development of dyslipidemia.
Current evidence does not suggest that the duration, dose, and type of corticosteroid administered influence the development of SEL [21] . All patients in the study were diagnosed with SEL after undergoing at least two successful LPs, and the majority of patients (10/14) were diagnosed within 1 month from the time of initial diagnosis. However, this first month of therapy features intensive systemic and intrathecal steroid administration in previously healthy patients (i.e., steroid-naïve). Childhood leukemia therapy, particularly steroid use, is an established risk factor for developing obesity [22, 23] . It is possible that accumulation of fat in the spinal canal as SEL is a direct extension of the typical truncal obesity that results from exogenous corticosteroid therapy.
We chose a cohort of patients with newly diagnosed ALL treated on a contemporary clinical trial during a similar time period to identify risk factors associated with development of SEL in children with hematologic malignancies. Though this comparison is limited due to the small number of SEL cases, heterogenous diagnoses and treatment, children that are older, black race, and overweight were significantly over-represented in the SEL cohort.
The diagnosis of SEL and additional compounding factors led to changes in the administration of subsequent intrathecal chemotherapy for eight patients, including placement of an Ommaya reservoir in four patients and modification of the technique (fluoroscopy in one patient or level of the lumbar puncture in three patients). Patients investigated for "difficult LP" demonstrating canal narrowing >25% by SEL and compounding risk factors such as congenital spinal canal stenosis frequently required interventions. No additional surgical procedure was required for the management of SEL in our patients compared to an adult series where 75-95% of patients underwent surgical laminectomy and debulking for symptomatic relief [5, 7] . Certain reports suggest that tapering the dose of corticosteroids may reduce complications of SEL [20, 24] . This strategy is neither feasible nor recommended for patients with hematologic malignancies. All patients in our study continued to receive protocol-specified systemic and intrathecal steroids without progression of symptoms or extent of SEL (in follow-up MRIs when available). None of the patients developed subsequent CNS relapse, suggesting that CNS-directed therapy was not compromised due to SEL.
In conclusion, though SEL is a rare disorder, it can significantly impact intrathecal therapy required in patients with leukemia/lymphoma. Limited by the retrospective nature of this review, we recognize the need for further study in the pediatric oncology population, including patients receiving corticosteroids for brain tumors or graftversus-host disease. Heightened awareness of this diagnosis, especially in patients with difficult or "low-flow" CSF during routine lumbar punctures, may help determine the true prevalence. Adoption of a more sophisticated imaging and grading technique, applied prospectively to patients imaged for a suspicion of SEL, could lead to a better identification of patients at risk. It may also help in formulating guidelines for optimal management by identifying patients who need immediate intervention (i.e., Ommaya reservoir placement) vs. those who could be managed conservatively. The recognition and appropriate management of SEL in patients with leukemia/lymphoma may help reduce unsuccessful LPs which can delay therapy or lead to traumatic lumbar punctures, directly impacting the quality of care for patients.
